<DOC>
	<DOCNO>NCT00797420</DOCNO>
	<brief_summary>The purpose study investigate pharmacokinetics safety fluconazole load dose infant toddler .</brief_summary>
	<brief_title>Pharmacokinetics ( PK ) Study Fluconazole Loading Dose Infants Toddlers</brief_title>
	<detailed_description>This open label study investigative pharmacokinetics safety fluconazole load dose infant toddler &lt; 2 year age suspect sepsis . There two treatment group : single fluconazole load dose 25 mg/kg ; fluconazole loading dose 25mg/kg follow 12 mg/kg daily total 5 day . There three age cohort within group : pre-term &lt; 30 week EGA infant &gt; 48 hour &lt; 31 day ; &gt; 30 week EGA infant &gt; 48 hour &lt; 31 day ; infant ≥ 31 day &lt; 2 year age . The study require administration fluconazole 1-5 day depend treatment group follow 1 week safety monitoring . Six eight 100 µL PK sample obtain 5 day drug administration . The risk reasonable vs. benefit minimize appropriately . There may benefit subject ( administration empirical antifungal therapy ) , information study may benefit large number infant toddler suspect proven fungal sepsis . There data analysis plan .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>suspect sepsis blood culture within 48 hour age ≥ 48 hour &lt; 2 year age sufficient venous access permit study drug administration allergic reaction azole history fluconazole administration prior 5 day liver dysfunction renal failure concomitant use cyclosporine , tacrolimus , azithromycin</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>fluconazole</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>candidiasis</keyword>
	<keyword>sepsis</keyword>
	<keyword>pediatric</keyword>
	<keyword>infant</keyword>
	<keyword>antifungal</keyword>
	<keyword>candidemia</keyword>
	<keyword>fungemia</keyword>
	<keyword>load dose</keyword>
</DOC>